Vericel Corporation (VCEL) Competitors & Peers
The 5 largest companies in the same industry as Vericel Corporation, by market value — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| VRTX | Peer | $526.19 | P/E 30.2RSI 51Cap 133.4 B |
| REGN | Peer | $788.04 | P/E 19.5RSI 48Cap 81.1 B |
| ARGX | Peer | $959.49 | P/E 36.5RSI 45Cap 60.0 B |
| RVMD | Peer | $204.97 | RSI 41Cap 41.4 B |
| ALNY | Peer | $255.96 | P/E 44.6RSI 56Cap 34.2 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Confirmed relationships (cited)
Sourced from a public filing or disclosure — each links to its origin.
- MDWDSupplier
MediWound manufactures NexoBrid, and Vericel holds the exclusive license to commercialize the product in North America.
Confirmed — SEC filing / public disclosuresec.gov ↗ - MATRICELSupplier
Matricel GmbH is the sole supplier of the collagen membrane component used in the manufacturing of MACI.
Confirmed — SEC filing / public disclosuresec.gov ↗ - JPMPartner
JPMorgan Chase Bank is the administrative agent and lender under Vericel's $150 million revolving credit agreement.
Confirmed — SEC filing / public disclosuresec.gov ↗ - ORSINISupplier
Orsini acts as a key specialty pharmacy partner distributing and coordinating reimbursement for Vericel's cellular therapy products.
Confirmed — SEC filing / public disclosuresec.gov ↗
Model-inferred relationships (unverified)
Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.
- SNNCompetitor
Smith & Nephew competes with Vericel in cartilage repair and advanced wound management technologies.
Model-inferred, unverified — treat as a lead, not evidence - ORGOCompetitor
Organogenesis and Vericel compete in the cellular therapy and advanced wound care markets.
Model-inferred, unverified — treat as a lead, not evidence - IARTCompetitor
Integra LifeSciences competes with Vericel in surgical tissue repair and wound dressing markets.
Model-inferred, unverified — treat as a lead, not evidence - MDXGCompetitor
Vericel and MiMedx compete in the cellular therapy and advanced wound care sectors.
Model-inferred, unverified — treat as a lead, not evidence